Dianthus Therapeutics, Inc. /DE/ - Common Stock, par value $0.001 per share (DNTH)

CUSIP: 252828108

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
43,212,667
Total 13F shares
35,126,689
Share change
+2,962,012
Total reported value
$765,706,199
Put/Call ratio
150%
Price per share
$21.80
Number of holders
94
Value change
+$63,092,353
Number of buys
47
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 252828108?
CUSIP 252828108 identifies DNTH - Dianthus Therapeutics, Inc. /DE/ - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Dianthus Therapeutics, Inc. /DE/ - Common Stock, par value $0.001 per share (DNTH) as of Q4 2024

As of 31 Dec 2024, Dianthus Therapeutics, Inc. /DE/ - Common Stock, par value $0.001 per share (DNTH) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,126,689 shares. The largest 10 holders included FMR LLC, Avidity Partners Management LP, Fairmount Funds Management LLC, Bain Capital Life Sciences Investors, LLC, Octagon Capital Advisors LP, RA CAPITAL MANAGEMENT, L.P., VR Adviser, LLC, BlackRock, Inc., TCG Crossover Management, LLC, and VANGUARD GROUP INC. This page lists 94 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.